Deep Learning Corpus Callosum Segmentation as a Neurodegenerative Marker in Multiple Sclerosis
Open Access
- 15 February 2021
- journal article
- research article
- Published by Wiley in Journal of Neuroimaging
- Vol. 31 (3) , 493-500
Abstract
Background and Purpose: Corpus callosum atrophy is a sensitive biomarker of multiple sclerosis (MS) neurodegeneration but typically requires manual 2D or volumetric 3D‐based segmentations. We developed a supervised machine learning algorithm, DeepnCCA, for corpus callosum segmentation and relate callosal morphology to clinical disability using conventional MRI scans collected in clinical routine.Methods: In a prospective study of 553 MS patients with 704 acquisitions, 200 unique 2D T2‐weighted MRI scans were delineated to develop, train, and validate DeepnCCA. Comparative FreeSurfer segmentations were obtained in 504 3D T1‐weighted scans. Both FreeSurfer and DeepnCCA outputs were correlated with clinical disability. Using principal component analysis of the DeepnCCA output, the morphological changes were explored in relation to clinical disease burden.Results: DeepnCCA and manual segmentations had high similarity (Dice coefficients 98.1.11%, 89.3.76%, for intracranial and corpus callosum area, respectively through 10‐fold cross‐validation). DeepnCCA had numerically stronger correlations with cognitive and physical disability as compared to FreeSurfer: Expanded disability status scale (EDSS) ±6 months (r = –.22 P = .002; r = –.17, P = .013), future EDSS (r = –.26, P<.001; r = –.17, P = .012), and future symbol digit modalities test (r = .26, P = .001; r = .24, P = .003). The corpus callosum became thinner with increasing cognitive and physical disability. Increasing physical disability, additionally, significantly correlated with a more angled corpus callosum.Conclusions: DeepnCCA (https://github.com/plattenmichael/DeepnCCA/) is an openly available tool that can provide fast and accurate corpus callosum measurements applicable to large MS cohorts, potentially suitable for monitoring disease progression and therapy response.Keywords
Funding Information
- Karolinska Institutet (Clinical Scientist Training Program, Researching Intern Grant)
- Merck (Grant for Multiple Sclerosis Innovation)
- Svenska Sällskapet för Medicinsk Forskning
This publication has 30 references indexed in Scilit:
- Age and sex effects on corpus callosum morphology across the lifespanHuman Brain Mapping, 2015
- Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal studyMultiple Sclerosis Journal, 2014
- Defining the clinical course of multiple sclerosisNeurology, 2014
- Corpus callosum shape changes in early Alzheimer’s disease: an MRI study using the OASIS brain databaseBrain Structure and Function, 2013
- Shape Analysis of the Corpus Callosum and Cerebellum in Female MS Patients with Different Clinical PhenotypesThe Anatomical Record, 2012
- Evaluating intensity normalization on MRIs of human brain with multiple sclerosisMedical Image Analysis, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal studyMultiple Sclerosis Journal, 2008
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 2005
- Measurement of Brain Structures with Artificial Neural Networks: Two- and Three-dimensional ApplicationsRadiology, 1999